Allogeneic Adipose-Derived Stem Cells Protect Fat Grafts at the Early Stage and Improve Long-Term Retention in Immunocompetent Rats
Allogeneic Adipose-Derived Stem Cells Protect Fat Grafts at the Early Stage and Improve Long-Term Retention in Immunocompetent Rats
复制标题
同种异体脂肪干细胞在早期阶段保护脂肪移植物并改善免疫活性大鼠的长期保留
DOI:
10.1007/s00266-015-0505-9
复制
发表时间:
2015-06
影响因子:
2.4
通讯作者:
Liu Xiaoyan
中科院分区:
文献类型:
--
作者:
Zhang Jun;Wang Yunchuan;Zhao Bin;Fan Lei;Bai Xiaozhi;Yang Longlong;Chang Peng;Hu Dahai;Liu Xiaoyan
BackgroundSyngeneic adipose-derived stem cells (ASCs) promote the survival of fat grafts. But it is unclear whether allogeneic ASCs have a similar protective effect. In this study, we investigated the protective effect of allogeneic ASCs in a fat graft model of immunocompetent rats.MethodsSyngeneic and allogeneic ASCs were derived from Lewis (LEW) and Norway-Brown rats, respectively. Fifty-four LEW rats were divided into three groups. Each LEW rat was injected subcutaneously at two paravertebral spots with adipose granules premixed with DMEM (AFT group), syngeneic ASCs (SYNG group), or allogeneic ASCs (ALLG group). Fat grafts were harvested at 7 and 14 days to examine apoptosis rates and immunochemistry staining was performed for Perilipin A and CD34. At 3 months, fat graft volume retentions were measured. The proportion of regulatory T (Treg) cells and the ratio of CD4/CD8 cells in blood were analyzed at 7 days.ResultsExpression of Perilipin A and CD34 was higher in the ALLG group than the AFT group at 14 days (P< 0.05). The apoptosis rate in the ALLG group decreased in comparison with the AFT group at 7 and 14 days (P< 0.05). At 3 months, allogeneic ASCs increased fat graft volume retentions (P< 0.05). No difference was found in the proportion of Treg cells and CD4/CD8 cells ratio between groups. There were no statistically significant difference between ALLG and SYNG groups at all time points (P> 0.05).ConclusionsAllogeneic ASCs protected fat grafts at the early stage and improved long-term volume retention in the fat graft model of immunocompetent rats with no or little obvious immune rejection.No Level AssignedThis journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
登录
查看更多内容
影响因子:
7.2
作者:
Piccinno, Maria Serena;Veronesi, Elena;Loschi, Pietro;Pignatti, Marco;Murgia, Alba;Grisendi, Giulia;Castelli, Ilaria;Bernabei, Daniela;Candini, Olivia;Conte, Pierfranco;Paolucci, Paolo;Horwitz, Edwin M.;De Santis, Giorgio;Iughetti, Lorenzo;Dominici, Massimo
通讯作者:
Dominici, Massimo
影响因子:
7.4
作者:
Choudhery MS;Badowski M;Muise A;Pierce J;Harris DT
通讯作者:
Harris DT
影响因子:
7.5
作者:
Gutiérrez-Fernández M;Rodríguez-Frutos B;Ramos-Cejudo J;Teresa Vallejo-Cremades M;Fuentes B;Cerdán S;Díez-Tejedor E
通讯作者:
Díez-Tejedor E
影响因子:
2.9
作者:
Cianfarani, Francesca;Toietta, Gabriele;Odorisio, Teresa
通讯作者:
Odorisio, Teresa
影响因子:
3.3
作者:
Y. Kubota;K. Kishi;H. Satoh;Takara Tanaka;H. Nakajima;T. Nakajima
通讯作者:
Y. Kubota;K. Kishi;H. Satoh;Takara Tanaka;H. Nakajima;T. Nakajima